PT  - JOURNAL ARTICLE
AU  - Sinclair, Heather Q.
ED  - Diener, Hans-Christophe
TI  - How Does Dabigatran Compare with Warfarin for Secondary Stroke Prevention? Subgroup Analysis of the RE-LY Study
DP  - 2010 Apr 01
TA  - MD Conference Express
PG  - 14--15
VI  - 10
IP  - 1
4099  - http://mdc.sagepub.com/content/10/1/14.short
4100  - http://mdc.sagepub.com/content/10/1/14.full
AB  - A subgroup analysis of the Randomized Evaluation of Long-term anticoagulant therapy [RE-LY; NCT00262600] trial revealed that dabigatran 110 mg or 150 mg twice daily is as effective as warfarin for stroke prevention in patients who have had a prior stroke or transient ischemic attack.